Elos Medtech AB (CHIX:ELOSBS) ROCE % : 12.52% (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Elos Medtech AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Elos Medtech AB's annualized ROCE % for the quarter that ended in Sep. 2023 was 12.52%.

Elos Medtech AB ROCE % Historical Data

The historical data trend for Elos Medtech AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elos Medtech AB ROCE % Chart

Elos Medtech AB Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROCE %

Get a 7-Day Free Trial

5.53

5.06

7.42

6.22

12.05

Elos Medtech AB Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															15.52	12.78	13.97	9.50	12.52

Elos Medtech AB ROCE % Calculation

Elos Medtech AB's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	108.258	/	( ( (1002.035 - 156.399)	+	(1126.397 - 175.347) )	/ 2 )
	=	108.258	/	( (845.636	+	951.05)	/ 2 )
	=	108.258	/	898.343
	=	12.05 %

Elos Medtech AB's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	163.6	/	( ( (1510.5 - 166.9)	+	(1560.2 - 289.8) )	/ 2 )
	=	163.6	/	( ( 1343.6	+	1270.4 )	/ 2 )
	=	163.6	/	1307
	=	12.52 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Elos Medtech AB (CHIX:ELOSBs) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Elos Medtech AB ROCE % Related Terms

Thank you for viewing the detailed overview of Elos Medtech AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elos Medtech AB (CHIX:ELOSBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elos Medtech AB (CHIX:ELOSBs) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Torsgatan 5B, Gothenburg, SWE, 411 04

Website

http://www.elosmedtech.com

Elos Medtech AB operates in the medical technology business. It develops and produces medical technology products and components. The company operates through three business segments including Dental, Orthopedics, and Life science. Some of its products include Implants, Screws, Plates, Prosthetics, and Drills.

Elos Medtech AB (CHIX:ELOSBS) Headlines

No Headlines